Sitrin R D, Pfeiffer F R, Rosenbloom J P, Cooper D J, Schmidt S J, Peterson D, Wellman G, Hoover J R, Weisbach J A
J Antibiot (Tokyo). 1980 Apr;33(4):383-92. doi: 10.7164/antibiotics.33.383.
An efficient synthesis of the key 3',4'-galacto epoxide intermediate 4 obtained from the known 5,6-O,O'-cyclohexylidene-N,N'-bis-(methoxycarbonyl)-4-O-[2,6-bis(methoxycarbony lamino)-alpha-D-glucopyranosyl]-2-deoxystreptamine (5) is described. Treatment of this epoxide with sodium azide, followed by reduction and acetylation, yielded the protected4'-amino-4'-deoxyneamine 18 (3',4'-diequatorial), whereas treatment with ammonia followed by acetylation yielded the protected 3'-amino-3'-deoxyneamine analog 19 with a diaxial configuration of its 3' and 4' positions. Reaction of the previously described protected 3',4'-allo epoxide 3 with sodium azide yielded separable mixtures of the protected 3'-amino-3'-deoxyneamine 14 and the protected diaxial 4'-amino-4'-deoxyneamine isomer 13, the ratios of products depending on the solvent temperature. Structural assignments for 13, 14, 18 and 19 were based on their PMR spectra. An additional 4'-amino-4'-deoxyneamine analog (24) with an axial configuration as its 4' position was also prepared by azide displacement of an approximately protected 4'-methanesulfonyl neamine intermediate 10. The five protected isomers were deblocked to yield a series of aminodeoxyneamine analogs (15, 16, 20, 21 and 25), all of which were less active in vitro than neamine against a group of Gram-positive and Gram-negative bacteria.
本文描述了一种从已知的5,6 - O,O'-环己叉基 - N,N'-双(甲氧基羰基) - 4 - O - [2,6 - 双(甲氧基羰基氨基) - α - D - 吡喃葡萄糖基] - 2 - 脱氧链霉胺(5)高效合成关键的3',4'-半乳糖环氧化物中间体4的方法。用叠氮化钠处理该环氧化物,然后进行还原和乙酰化,得到受保护的4'-氨基 - 4'-脱氧新霉素B 18(3',4'-双平伏键),而用氨处理后再进行乙酰化,则得到其3'和4'位具有双直立构型的受保护的3'-氨基 - 3'-脱氧新霉素B类似物19。先前描述的受保护的3',4'-别环氧化物3与叠氮化钠反应,生成受保护的3'-氨基 - 3'-脱氧新霉素B 14和受保护的直立型4'-氨基 - 4'-脱氧新霉素B异构体13的可分离混合物,产物比例取决于溶剂温度。13、14、18和19的结构归属基于它们的核磁共振氢谱。还通过对一个大致受保护的4'-甲磺酰基新霉素B中间体10进行叠氮取代反应,制备了另一种4'位具有直立构型的4'-氨基 - 4'-脱氧新霉素B类似物(24)。将这五种受保护的异构体脱保护,得到一系列氨基脱氧新霉素B类似物(15、16、20、21和25),所有这些类似物在体外对一组革兰氏阳性和革兰氏阴性细菌的活性均低于新霉素B。